48. Oliver M.H., Harding J.E., Breier B.H., Evans P.C., Gluckman P.D. Glucose but not a mixed amino acid infusion regulates plasma insulin-like growth factor-I concentrations in fetal sheep // Pediatr. Res. 1993. Vol. 34, N 1. P. 62–65. DOI: 10.1203/00006450-199307000-00015.
49. Han V.K.M., Fowden A. Paracrine regulation of fetal growth // ed. by R.H.T. Ward, S.K. Smith, D. Donnai. Early fetal growth and development. London: RCOG Press; 1994. P. 275–291.
50. Stephens E., Thureen P.J., Goalstone M.L., Anderson M.S., Leitner J.W., Hay W.W. et al. Fetal hyperinsulinemia increases farnesylation of p21 Ras in fetal tissues // Am. J. Physiol. Metab. [Internet]. 2001. Vol. 281, N 2. P. E217–E223. DOI: 10.1152/ajpendo.2001.281.2.E217.
51. Kennaugh J.M., Bell A.W., Teng C., Meschia G., Battaglia F.C. Ontogenetic changes in the rates of protein synthesis and leucine oxidation during fetal life // Pediatr. Res. 1987. Vol. 22, N 6. P. 688–692. DOI: 10.1203/00006450-198712000-00015.
52. Wilkening R.B., Boyle D.W., Teng C., Meschia G., Battaglia F.C. Amino acid uptake by the fetal ovine hindlimb under normal and euglycemic hyperinsulinemic states // Am. J. Physiol. Metab. 1994. Vol. 266, N 1. P. E72–E78. DOI: 10.1152/ajpendo.1994.266.1.E72.
53. Magnusson-Olsson A.L., Hamark B., Ericsson A., Wennergren M., Jansson T., Powell T.L. Gestational and hormonal regulation of human placental lipoprotein lipase // J. Lipid. Res. 2006. Vol. 47, N 11. P. 2551–2561. DOI: 10.1194/jlr.M600098-JLR200.
54. Magnusson A.L., Waterman I.J., Wennergren M., Jansson T., Powell T.L. Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes // J. Clin. Endocrinol. Metab. [Internet]. 2004. Vol. 89, N 9. P. 4607–4614. DOI: 10.1210/jc.2003-032234.
55. Starikov R.S., Inman K., Has P., Iqbal S.N., Coviello E., He M. Correlation of placental pathology and perinatal outcomes with Hemoglobin A1c in early pregnancy in gravidas with pregestational diabetes mellitus // Placenta. 2017. Vol. 52. P. 94–99. DOI: 10.1016/j.placenta.2017.02.024.
56. International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels, Belgium: International Diabetes Federation, 2019.
57. Khong T.Y., Mooney E.E., Ariel I., Balmus N.C., Boyd T.K., Brundler M.A. et al. Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group Consensus Statement // Arch. Pathol. Lab. Med. 2016. Vol. 140, N 7. P. 698–713. DOI: 10.5858/arpa.2015-0225-CC.
58. Blackburn S. Maternal, fetal & neonatal physiology. 4th ed. Saunders; Maryland Heights, 2013. P. 79–85.
59. Cuffe J.S.M., Holland O., Salomon C., Rice G.E., Perkins A.V. Review: placental derived biomarkers of pregnancy disorders // Placenta. 2017. Vol. 54. P. 104–110. DOI: 10.1016/j.placenta.2017.01.119.
60. Schoots M.H., Gordijn S.J., Scherjon S.A., van Goor H., Hillebrands J.L. Oxidative stress in placental pathology // Placenta. 2018. Vol. 69. P. 153–161. DOI: 10.1016/j.placenta.2018.03.003.
61. American Diabetes Association. Standards of medical care in diabetes — 2014 // Diabetes Care. 2014. Vol. 37. Suppl. 1. P. S14–S80. DOI: 10.2337/dc14-S014.
62. Hahn T., Barth S., Weiss U., Mosgoeller W., Desoye G. Sustained hyperglycemia in vitro down-regulates the GLUT1 glucose transport system of cultured human term placental trophoblast: a mechanism to protect fetal development? // FASEB J. 1998. Vol. 12, N 12. P. 1221–1231. DOI: 10.1096/fasebj.12.12.1221.
63. Osmond D.T., Nolan C.J., King R.G., Brennecke S.P., Gude N.M. Effects of gestational diabetes on human placental glucose uptake, transfer, and utilisation // Diabetologia. 2000. Vol. 43, N 5. P. 576–582. DOI: 10.1007/s001250051346.
64. Cetin I., de Santis M.S., Taricco E., Radaelli T., Teng C., Ronzoni S. et al. Maternal and fetal amino acid concentrations in normal pregnancies and in pregnancies with gestational diabetes mellitus // Am. J. Obstet. Gynecol. 2005. Vol. 192, N 2. P. 610–617. DOI: 10.1016/j.ajog.2004.08.011.
65. Капустин Р.В., Оноприйчук А.Р., Аржанова О.Н. и др. Патофизиология плаценты и плода при сахарном диабете // Журнал акушерства и женских болезней. 2018. № 6. С. 79–92.
66. Huynh J., Dawson D., Roberts D., Bentley-Lewis R. A systematic review of placental pathology in maternal diabetes mellitus // Placenta. 2015. Vol. 36, N 2. P. 101–114. DOI: 10.1016/j.placenta.2014.11.021.
67. Roescher A.M., Hitzert M.M., Timmer A., Verhagen E.A., Erwich J.J., Bos A.F. Placental pathology is associated with illness severity in preterm infants in the first twenty-four hours after birth // Early Hum. Dev. 2011. Vol. 87, N 4. P. 315–319. DOI: 10.1016/j.earlhumdev.2011.01.040.
68. Taricco E., Radaelli T., Nobile de Santis M.S., Cetin I. Foetal and placental weights in relation to maternal characteristics in gestational diabetes // Placenta. 2003. Vol. 24, N 4. P. 343–347. DOI: 10.1053/plac.2002.0913.
69. Evers I.M., Nikkels P.G., Sikkema J.M., Visser G.H. Placental pathology in women with type 1 diabetes and in a control group with normal and large-for-gestational-age infants // Placenta. 2003. Vol. 24, N 8–9. P. 819–825. DOI: 10.1016/s0143-4004(03)00128-0.
70. Траль Т.Г., Толибова Г.Х., Мусина Е.В. и др. Молекулярно-морфологические особенности формирования хронической плацентарной недостаточности, обусловленной разными типами сахарного диабета (обзор) // Сахарный диабет. 2020. Т. 23, № 2. С. 185–191.
71. Desoye G., Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network // Diabetes Care. 2007. Vol. 30. Suppl. 2. P. S120-S126. DOI: 10.2337/dc07-s203.
72. Huynh J., Yamada J., Beauharnais C., Wenger J.B., Thadhani R.I., Wexler D. et al. Type 1, type 2 and gestational diabetes mellitus differentially impact placental pathologic characteristics of uteroplacental malperfusion // Placenta. 2015. Vol. 36, N 10. P. 1161–1166. DOI: 10.1016/j.placenta.2015.08.004.